Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Active not recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Carcinoma, Transitional Cell 9Carcinoma, Merkel Cell 7Neoplasm Metastasis 6Breast Neoplasms 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Melanoma 4Urethral Neoplasms 3Ureteral Neoplasms 3Skin Neoplasms 3Carcinoma, Renal Cell 3Ovarian Neoplasms 2Neuroendocrine Tumors 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thymoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Peritoneal Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Motor Activity 1Microsatellite Instability 1

Interventions

pembrolizumab 7cemiplimab 6Nivolumab 5avelumab 3encorafenib 2binimetinib 2Radiotherapy 2Ipilimumab 2Immune Checkpoint Inhibitors 2Blood Specimen Collection 2toripalimab 1tislelizumab 1lifileucel 1lenvatinib 1durvalumab 1dostarlimab 1cobimetinib 1atezolizumab 1Vemurafenib 1Surveys and Questionnaires 1Sirolimus 1Radiosurgery 1Prednisone 1Paclitaxel 1Oxaliplatin 1Observation 1Mohs Surgery 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Skin Neoplasms × avelumab × Clear all
NCT03944941 2026-06-02

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
60 enrolled 19 charts
Dermatologic

Skin Neoplasms

NCT04387084 2026-03-23

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

University of Southern California

Phase 1 Active not recruiting
10 enrolled
Dermatologic

Skin Neoplasms

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡